IOVA 7.38 (+2.22%)
US4622601007BiotechnologyBiotechnology

Iovance Biotherapeutics (IOVA) Stock Highlights

7.38 | +2.22%
2024-12-21 02:56:55
Iovance Biotherapeutics Inc is a clinical-stage biopharmaceutical company. The company focused on the development and commercialization of cell therapies as novel cancer immunotherapy products designed to harness the power of a patients immune system to eradicate cancer cells. Its lead pipeline candidate, LN-145, is an adoptive cell therapy using tumor-infiltrating lymphocytes to treat patients with refractory metastatic melanoma.

Statistics

Range Today
7.07 7.44
Volume Today 11.17M
Range 1 Year
6.7 18.33
Volume 1 Year 1.85B
Range 3 Year
3.21 20.6
Volume 3 Year 4.05B
Range 10 Year
3.21 54.21
Volume 10 Year 5.97B

Highlights

Market Capitalization 3.23B (mid)
Floating Shares 206.5M
Current Price 7.38
Price To Earnings -7.4
Price To Book 4.64
Earnings Per Share -1.44
Payout Ratio 0%

Performance

Latest +2.22%
1 Month -10.11%
3 Months -28.9%
6 Months -5.63%
1 Year -5.38%
3 Years -61.4%
5 Years -73.64%
10 Years -4.16%

Benchmarks


Obligatory risk notice

We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.